Synergistic induction of inflammation by bacterial products lipopolysaccharide and fMLP: An important microbial pathogenic mechanism

Ling Yu Chen, Warren W. Pan, Miao Chen, Jain Dong Li, Wei Liu, Guoqiang Chen, Shuang Huang, Thomas J. Papadimos, Zhixing K. Pan

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

A wide variety of stimuli have been shown to induce inflammation, but bacteria products/components are considered the major inducers during bacterial infections. We previously demonstrated that bacterial products/components such as LPS, a glycolipid component of the bacterial outer membrane, and formylated peptides (fMLP), a bacterial-derived peptide, induced proinflammatory cytokine gene expression in human peripheral blood monocytes. We now present evidence that mixtures of bacterial products/components LPS and fMLP behave synergistically in the induction of inflammation in vitro and in vivo. Furthermore, our results indicate that the TLR4 and the IKKβ- IκBα signaling pathways are involved in the synergistic induction of inflammatory cytokines. The mechanism of synergistic activation of NF-κB is depended on nuclear translocation of p65 and phosphorylation of p65 at both Ser536 and Ser276 sites. These results demonstrate an important role for bacterial products/components from lysed bacteria in the pathogenesis of infectious diseases. We believe that this synergistic induction of inflammation by bacterial products LPS and fMLP represents an important pathogenic mechanism during bacterial infection, which may suggest novel therapeutic strategies or targets to minimize host injury following bacterial infection.

Original languageEnglish (US)
Pages (from-to)2518-2524
Number of pages7
JournalJournal of Immunology
Volume182
Issue number4
DOIs
StatePublished - Feb 15 2009

Fingerprint

Lipopolysaccharides
Bacterial Infections
Inflammation
Peptides
Cytokines
Bacteria
Glycolipids
Communicable Diseases
Monocytes
Phosphorylation
Gene Expression
Membranes
Wounds and Injuries
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Synergistic induction of inflammation by bacterial products lipopolysaccharide and fMLP : An important microbial pathogenic mechanism. / Chen, Ling Yu; Pan, Warren W.; Chen, Miao; Li, Jain Dong; Liu, Wei; Chen, Guoqiang; Huang, Shuang; Papadimos, Thomas J.; Pan, Zhixing K.

In: Journal of Immunology, Vol. 182, No. 4, 15.02.2009, p. 2518-2524.

Research output: Contribution to journalArticle

Chen, LY, Pan, WW, Chen, M, Li, JD, Liu, W, Chen, G, Huang, S, Papadimos, TJ & Pan, ZK 2009, 'Synergistic induction of inflammation by bacterial products lipopolysaccharide and fMLP: An important microbial pathogenic mechanism', Journal of Immunology, vol. 182, no. 4, pp. 2518-2524. https://doi.org/10.4049/jimmunol.0713933
Chen, Ling Yu ; Pan, Warren W. ; Chen, Miao ; Li, Jain Dong ; Liu, Wei ; Chen, Guoqiang ; Huang, Shuang ; Papadimos, Thomas J. ; Pan, Zhixing K. / Synergistic induction of inflammation by bacterial products lipopolysaccharide and fMLP : An important microbial pathogenic mechanism. In: Journal of Immunology. 2009 ; Vol. 182, No. 4. pp. 2518-2524.
@article{e2e1855502f348d89a7137cab8a5cb73,
title = "Synergistic induction of inflammation by bacterial products lipopolysaccharide and fMLP: An important microbial pathogenic mechanism",
abstract = "A wide variety of stimuli have been shown to induce inflammation, but bacteria products/components are considered the major inducers during bacterial infections. We previously demonstrated that bacterial products/components such as LPS, a glycolipid component of the bacterial outer membrane, and formylated peptides (fMLP), a bacterial-derived peptide, induced proinflammatory cytokine gene expression in human peripheral blood monocytes. We now present evidence that mixtures of bacterial products/components LPS and fMLP behave synergistically in the induction of inflammation in vitro and in vivo. Furthermore, our results indicate that the TLR4 and the IKKβ- IκBα signaling pathways are involved in the synergistic induction of inflammatory cytokines. The mechanism of synergistic activation of NF-κB is depended on nuclear translocation of p65 and phosphorylation of p65 at both Ser536 and Ser276 sites. These results demonstrate an important role for bacterial products/components from lysed bacteria in the pathogenesis of infectious diseases. We believe that this synergistic induction of inflammation by bacterial products LPS and fMLP represents an important pathogenic mechanism during bacterial infection, which may suggest novel therapeutic strategies or targets to minimize host injury following bacterial infection.",
author = "Chen, {Ling Yu} and Pan, {Warren W.} and Miao Chen and Li, {Jain Dong} and Wei Liu and Guoqiang Chen and Shuang Huang and Papadimos, {Thomas J.} and Pan, {Zhixing K.}",
year = "2009",
month = "2",
day = "15",
doi = "10.4049/jimmunol.0713933",
language = "English (US)",
volume = "182",
pages = "2518--2524",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "4",

}

TY - JOUR

T1 - Synergistic induction of inflammation by bacterial products lipopolysaccharide and fMLP

T2 - An important microbial pathogenic mechanism

AU - Chen, Ling Yu

AU - Pan, Warren W.

AU - Chen, Miao

AU - Li, Jain Dong

AU - Liu, Wei

AU - Chen, Guoqiang

AU - Huang, Shuang

AU - Papadimos, Thomas J.

AU - Pan, Zhixing K.

PY - 2009/2/15

Y1 - 2009/2/15

N2 - A wide variety of stimuli have been shown to induce inflammation, but bacteria products/components are considered the major inducers during bacterial infections. We previously demonstrated that bacterial products/components such as LPS, a glycolipid component of the bacterial outer membrane, and formylated peptides (fMLP), a bacterial-derived peptide, induced proinflammatory cytokine gene expression in human peripheral blood monocytes. We now present evidence that mixtures of bacterial products/components LPS and fMLP behave synergistically in the induction of inflammation in vitro and in vivo. Furthermore, our results indicate that the TLR4 and the IKKβ- IκBα signaling pathways are involved in the synergistic induction of inflammatory cytokines. The mechanism of synergistic activation of NF-κB is depended on nuclear translocation of p65 and phosphorylation of p65 at both Ser536 and Ser276 sites. These results demonstrate an important role for bacterial products/components from lysed bacteria in the pathogenesis of infectious diseases. We believe that this synergistic induction of inflammation by bacterial products LPS and fMLP represents an important pathogenic mechanism during bacterial infection, which may suggest novel therapeutic strategies or targets to minimize host injury following bacterial infection.

AB - A wide variety of stimuli have been shown to induce inflammation, but bacteria products/components are considered the major inducers during bacterial infections. We previously demonstrated that bacterial products/components such as LPS, a glycolipid component of the bacterial outer membrane, and formylated peptides (fMLP), a bacterial-derived peptide, induced proinflammatory cytokine gene expression in human peripheral blood monocytes. We now present evidence that mixtures of bacterial products/components LPS and fMLP behave synergistically in the induction of inflammation in vitro and in vivo. Furthermore, our results indicate that the TLR4 and the IKKβ- IκBα signaling pathways are involved in the synergistic induction of inflammatory cytokines. The mechanism of synergistic activation of NF-κB is depended on nuclear translocation of p65 and phosphorylation of p65 at both Ser536 and Ser276 sites. These results demonstrate an important role for bacterial products/components from lysed bacteria in the pathogenesis of infectious diseases. We believe that this synergistic induction of inflammation by bacterial products LPS and fMLP represents an important pathogenic mechanism during bacterial infection, which may suggest novel therapeutic strategies or targets to minimize host injury following bacterial infection.

UR - http://www.scopus.com/inward/record.url?scp=61449238091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61449238091&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.0713933

DO - 10.4049/jimmunol.0713933

M3 - Article

C2 - 19201908

AN - SCOPUS:61449238091

VL - 182

SP - 2518

EP - 2524

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 4

ER -